Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
Accumulated Depreciation
Dexcom Inc
Accumulated Depreciation Peer Comparison
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dexcom Inc
NASDAQ:DXCM
|
Accumulated Depreciation
-$549m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accumulated Depreciation
-$7.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-6%
|
|
Boston Scientific Corp
NYSE:BSX
|
Accumulated Depreciation
-$3.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
Stryker Corp
NYSE:SYK
|
Accumulated Depreciation
-$3.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
Abbott Laboratories
NYSE:ABT
|
Accumulated Depreciation
-$11.9B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-5%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Dexcom Inc's Accumulated Depreciation?
Accumulated Depreciation
-549m
USD
Based on the financial report for Mar 31, 2024, Dexcom Inc's Accumulated Depreciation amounts to -549m USD.
What is Dexcom Inc's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-44%
Over the last year, the Accumulated Depreciation growth was -39%. The average annual Accumulated Depreciation growth rates for Dexcom Inc have been -47% over the past three years , -44% over the past five years .